ArticleCureus2025
A Rare Case of Low-Grade Endometrial Stromal Sarcoma: Diagnostic Insights and Therapeutic Considerations.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-grade endometrial stromal sarcoma (LGESS) is a rare malignant tumor of the uterus, often misdiagnosed due to its indolent progression and nonspecific clinical presentation. We report the case of a 49-year-old perimenopausal woman who presented with abnormal uterine bleeding and pelvic pain. Pelvic ultrasound and MRI revealed a heterogeneous uterine mass. The patient underwent a total hysterectomy, and definitive histopathology confirmed the diagnosis of LGESS. This case underscores the importance of including LGESS in the differential diagnosis of abnormal uterine bleeding in perimenopausal women. Early diagnosis and complete surgical excision remain the cornerstone of treatment, and long-term follow-up is crucial due to the risk of late recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.